Mammotome MammoStar Biopsy Site Identified, REF STAR1401 — FDA record Z-1041-2023

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Dec 16, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Mammotome MammoStar Biopsy Site Identified, REF STAR1401
Reason
The label incorrectly identifies the product as STAR1401, a 1x3mm Barbell shaped marker pre-loaded in a 14 gauge needle, while the packaging contains STAR1402, a 1x5mm Tribell shaped marker pre-loaded in a 14 gauge needle.
Classification
Class II
Recalling firm
Carbon Medical Technologies, Inc.
Quantity
550 devices
Agency-reported status
Terminated
Source record identifier
Z-1041-2023

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityUDI/DI 00858015005431, Lot Number 2201011A

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

US Nationwide distribution in the state of OHIO.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Feb 8, 2023
Recall initiation date
Dec 16, 2022
Center classification date
Jan 30, 2023
Termination date
Aug 9, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records